It is important to point out the MYC expression is frequently deregulated in cancer cells; indeed, its expression is increased in a wide variety of human cancers, including 80% of breast cancer, 70% of colon cancer, and 50% of hepatocellular carcinomas (Gardner et al., 2002). The gene discussed is MYC; the disease is hepatocellular carcinoma.